DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20190313

Role of low dose Magnesium sulphate in eclampsia

Kajal Sinha, Shail K. Sinha

Abstract


Background: Eclampsia is one of the challenging medical complications seen during pregnancy. With the use of magnesium sulphate for control of convulsion in eclampsia, it can be managed effectively.

Methods: This is a prospective study done in a tertiary care hospital. Considering low body mass index of patients of developing area, authors had used low dose regime of magnesium sulphate. 100 patients had been enrolled for low dose magnesium sulphate regime after categorizing patients as per inclusion and exclusion criteria. The primary outcome to be measured was recurrence of fits in any patients who received low dose magnesium sulphate. The secondary outcome measured were development of any toxicity, level of serum magnesium level, maternal and perinatal outcome.

Results: It was observed that 93% of the patients responded to low dose regime. 7% developed  recurrence of fits for that additional dose of 2 gram of 20% magnesium sulphate was given to the patients. Not even a single patient developed signs of toxicity. 94% and 95% of the patients acquired therapeutic level of serum magnesium at 4 hours and 10 hours of magnesium sulphate administration, respectively. Maternal mortality was 5% and perinatal mortality was 24.4%.

Conclusions: Low dose of magnesium sulphate can prevent and treat eclampsia. Low dose regimen also reduces incidence of toxicity with improved maternal and perinatal outcome.


Keywords


Eclampsia, Magnesium sulphate, Maternal mortality, Perinatal outcome

Full Text:

PDF

References


The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet. 1995;345(8963):1455-63.

Cunningham, F Gary, Williams: Williams Obstetrics, Williams obstetrics / editors, F. Gary Cunningham, Kenneth J. Leveno, Steven L. Bloom, Jodi S. Dashe, Barbara L. Hoffman, Brian M. Casey, Catherine Y. Spong 22nd International edition. New York: McGraw-Hill. 2005; pp440-60.

Pritchard JA. The use of the magnesium ion in the management of eclamptogenic toxemias. Surgery, Gynecology Obstetrics. 1955;100(2):131-40.

Flowers CE, Easterling WE, White FD, Jung JM, Fox JT. Magnesium sulfate in toxemia of pregnancy: new dosage schedule based on body weight. Obstet Gynecol. 1962;19(3):315-27.

Sardesai Suman, Maira Shivanjali, Patil Ajit et al. Low dose magnesium sulphate therapy for eclampsia and imminent eclampsia- Regime tailored for Indian women. J. Obstet Gynecol India 2003;53(6):546-50.

Sardesai S. Low dose magnesium sulphate therapy for eclampsia and imminent eclampsia- Regime tailored for Indian women. J. Obstet Gynecol India. 2003;3:546-50.

Douglas KA, Redman CW. Eclampsia in the United Kingdom BMJ. 1994;309(6966):1395-400.

Ventura SJ, Martin JA, Curtin SC, Matthews TJ, Park MM. Births: final data for 1998. Hyattsville, MD: National Center for Health Statistics; 2000.

World Health Organisation International. Collaborative Study of Hypertensive Disorders of pregnancy. Geographic Variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol. 1958:158(1):80-3.

Crowther CA. Eclampsia at Harare Maternity Hospital. An epidemiological study. South African Med J Suid-Afrikaanse Tydskrif Vir Geneeskunde. 1985;68(13):927-9.

Bergström S, Povey G, Songane F, Ching CH. Seasonal incidence of eclampsia and its relationship to meteorological data in Mozambique. J Perinat Med. 1992;20(2):153-8.

Helmin R H J. Prevention of eclampsia and pre-eclampsia. Lancet. 1952;1:64.

Bangal V, Kwatra A, Raghav S, Jadhav S. Low dose magnesium sulphate regime for Eclampsia. Pravara Med Rev. 2009;4(3):13-5.

Toxaemia of pregnancy. ln: Dawn CS, Textbook of Obstetrics .Eighth ed. Calcutta. Dawn books,1982:pp 172-202.

Begum R, Begum A, Johanson R, Ali MN, Akhter S. A low dose ('Dhaka') magnesium sulphate regime for eclampsia: Clinical findings and serum magnesium levels. Acta obstetricia et gynecologica Scandinavica. 2001;80(11):998-1002.

Costantine MM, Weiner SJ. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol. 2009;114(2 Pt 1):354-64.